Completed
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
NCT03833934
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States